Article and Video

Articles and Videos

Article 7: Can PROTACs Truly Become Oral Drugs?

July 22, 2026
Illustration of the three pillars of oral bioavailability, solubility, dissolution rate and permeability, showing how NanoGlass™ formulations support exposure for poorly soluble APIs.

Article 6: The 3 Pillars of Bioavailability.

May 13, 2026

Webinar: Solving Bioavailability in Two Weeks

April 24, 2026
Scientist handling test tubes with blue liquid in a laboratory during pharmaceutical formulation work

Article 5: A Formulation Perspective On Protein Degraders

February 9, 2026
Researcher pipetting a NanoGlass™ formulation into a multiwell plate as part of SeraNovo’s in vitro testing workflow, with a chemical structure diagram in the background.

Predicting In Vivo Performance Through In Vitro Partitioning

November 20, 2025
Scientist using pipette for GLP toxicology formulation development in SeraNovo laboratory

Frequently Asked Questions (FAQ)

September 24, 2025
Three translucent capsules arranged in a row on a smooth surface, used as the cover image for SeraNovo’s first webinar.

Webinar#2: Advancing Lipid-Based Drug Delivery with Maisine® CC and LiGlass™

May 22, 2025
Three translucent capsules arranged in a row on a smooth surface, used as the cover image for SeraNovo’s first webinar.

Webinar#1: Achieving High Drug Loading and Improved Bioavailability in Capryol® 90 with LiGlass™

April 22, 2025
Close-up of liquid drop from pipette into test tube, representing ARV-110 case study in SeraNovo's advanced drug formulation research.

Improved Bioavailability of ARV-110 by 5.6x

March 14, 2025
Load More